Remedee Labs News

Remedee Labs, a French start-up that specializes in non-pharmaceutical chronic pain management and just announced the positive results of its clinical study on osteoarthritis is

Remedee Labs, a French startup that specializes in non-pharmaceutical treatments for chronic pain, is announcing the highly anticipated results of its clinical study assessing the

February 1st, 2023 – Today, the French pharmaceutical company UPSA and the startup Remedee Labs are announcing the signature of a partnership to offer healthcare

On World Fibromyalgia Awareness Day (May 12), the French startup Remedee Labs is announcing that the FDA has granted Breakthrough Device Designation to its endorphin

Remedee Labs, a Grenoble-based startup specializing in integrated chronic pain care centered on its unique endorphin stimulation technology, is joining Future4care, the digital health startup

French health tech startup Remedee Labs, designer of the first endorphin stimulator for personal use, is hiring Gilles Litman to accelerate growth. As Chief Business

MedTech Innovator is the industry’s nonprofit global competition and accelerator for medical device, digital health and diagnostic companies. Their mission is to improve the lives

The challenge of measuring endorphin levels The analgesic effect of millimeter wave (MMW) therapy is due to the release of endogenous opioid – endorphins –

The CHU Grenoble research hospital in France has started a clinical trial to evaluate the efficacy of the Remedee Labs endorphin stimulation therapy for peri-surgical

We have developed the first personal endorphin stimulator using advanced millimeter wave technology for electronic pain management. Dubbed the “electronic pain medication”, the solution stimulates

Funding to support new endorphin-stimulation pain therapy clinical trials, including arthritic pain, peri-surgical pain relief and migraine Meylan, France, – 14 November 2019 –  French startup